pharmacist Login
* Forgot your username? * Forgot your password?

Customer login

  • »   Apply for an IPD account
  • »   Register for Online Access
  • »   Important Recall Information
  • _
 pharmacy Services Offered
  • No Contracts Or Monthly Minimums
  • Upfront Rebate Pricing
  • Personalized Sales Rep
  • Free Next Day Delivery (Orders of $200 or more)
  • Saturday Free Delivery
  • Industry Leading Services, Shortages, Price Erosion
  • Great Savings
  • CSOS Capability
Additional BENEFITS
 pharmacist on phone Pharmacy Resources

Important Recall Information

Click on the link below to view the recall…

Accord Recall – Jan. 2023

Accord Recall – Feb. 2023

Accord Recall – Mar. 2023

Accord Cinacalcet Recall – Oct. 2024

Accord Levothyroxine Recall – Nov. 2024

Advagen Tramadol Recall – May. 2024

ANI Digoxin Recall – Mar. 2024

Ascend Dabigatran Recall – Dec. 2024

Ascend Fosfomycin Recall – Jan. 2024

Ascend Fosfomycin Recall – Jul. 2023

Ascend Mycophenolic Recall – 1 Sep. 2024

Ascend Mycophenolic Recall – 2 Sep. 2024

Bausch Health Omeprazole and Sodium Bicarb Recall – Feb. 2024

Bausch Health Omeprazole and Sodium Bicarb Recall – Mar. 2024

Glenmark Chlorpromazine Acetate Recall – Dec. 2024

Glenmark Desmopressin Acetate Recall

Glenmark Diltiazem Recall – May. 2024

Glenmark Diltiazem Recall – Nov. 2024

Glenmark Hydrochloride Recall – Dec. 2024

Glenmark Esomeprazole Recall

Glenmark Mupirocin Ointment Recall – Aug. 2024

Glenmark Mupirocin Recall – Sep. 2024

Glenmark Potassium Recall – Jun. 2024

Glenmark Potassium Recall Response Form Jun. – 2024

Glenmark Potassium Chloride Recall – May. 2024

Glenmark Pravastatin Recall – Jul. 2024

Glenmark Tacrolimus Ointment Recall

Glenmark Tacrolimus Recall

Glenmark Zonisamide Recall

Jubilant Cadista Recall

Leading Pharma Recall Jul. 2024

Lupin Pharma Cefdinir Recall – May. 2024

Major Magnesium Citrate Recall

Major Polyvinyl Alcohol, 1.4 Eye Drops Recall

Major Povidone Lodine Recall – Sep. 2024

Major Tears Eye Drops Recall

Padagis Diclofenac Sodium Recall

Padagis Triamcinolone Recall

Rising Duloxetine Recall – Nov. 2024

Stason Pharmaceuticals Recall – Feb. 2024

Sun Pharma Esomeprazole Recall

Sun Pharma Liothyronine 5mcg Recall

Sun Pharma Liothyronine 5mcg & 25mcg Recall

Sun Pharma Lurasidone Recall – Jan. 2024

Sun Pharma Medroxyprogesterone Recall

Sun Pharma Niacin Recall – Jan. 2024

Sun Pharma Nitrofurantoin Recall – Jul. 2024

Sun Pharma Testosterone Recall

Sun Pharma Tiagabine Hydrochloride Recall

Teligent Recall

Westminster Pharmaceuticals Recall

Oxycodone Recall Scam Notice NCPA

Sadly, ‘tis the season for scammers

NCPA December 16, 2022

A new form of fraud is making its way to independent pharmacies via fax and email with phony recall notices. Pharmacies and health care entities are receiving fraudulent recall notices regarding Oxycodone Hydrochloride. The NDC 0406853001 (Specgx Llc, 100 count bottle) may be listed in communications, however, no manufacturer recall exists for this product at this time for any lot. Emails/faxes being sent include a letter, spoofed as being from a legitimate pharma distributor, indicating the following:

(Distributor) is updating all direct account Wholesalers, Distributors and pharmacies that have received the impacted NDC below. We are initiating a recall of lots distributed to date on a precautionary basis. This recall is being conducted at the Retail Level. Please note all lots are being recalled. Thank you.

example

So far, no fraudulent attempts have been successful.

Law enforcement authorities investigating these incidents ask that all companies and industry associations make their employees/members aware of this new tactic. If one of your employees/members were to receive any communication which references ANY type of a recall, they should document as much about the interaction as possible. That should be followed with a call to a known contact of your distributor partner to determine if the request is legitimate. If it isn’t, report the occurrence to the PCSC at cforsaith@hda.org or call 401-623-1344 as soon as reasonably possible. All attempts, successful or not, need to be documented to further the overall investigation.

NCPA